See every side of every news story
Published loading...Updated

Immunotherapy implant shows promise as pancreatic cancer treatment

Summary by rarecancernews.com
A new approach in immunotherapy that can safely boost the body’s immune response has shown promise in hard-to-treat tumors like pancreatic cancers, a study finds. Researchers from the Rice Biotech Launch Pad at Rice University developed a tiny implantable device made of engineered cells that locally release interleukin-12 (IL-12), a powerful immune-activating molecule, directly at the tumor site. Referred to as an IL-12 “cytokine factory,” the d…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

rarecancernews.com broke the news in on Friday, April 11, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.